Asset Details
Do you wish to reserve the book?
Proteomic Profiling of Exosomes Leads to the Identification of Novel Biomarkers for Prostate Cancer
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Proteomic Profiling of Exosomes Leads to the Identification of Novel Biomarkers for Prostate Cancer
Do you wish to request the book?
Proteomic Profiling of Exosomes Leads to the Identification of Novel Biomarkers for Prostate Cancer
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Proteomic Profiling of Exosomes Leads to the Identification of Novel Biomarkers for Prostate Cancer
2013
Overview
Current markers for prostate cancer, such as PSA lack specificity. Therefore, novel biomarkers are needed. Unfortunately, the complexity of body fluids often hampers biomarker discovery. An attractive alternative approach is the isolation of small vesicles, i.e. exosomes, ∼100 nm, which contain proteins that are specific to the tissue from which they are derived and therefore can be considered as treasure chests for disease-specific biomarker discovery.
Exosomes were isolated from 2 immortalized primary prostate epithelial cells (PNT2C2 and RWPE-1) and 2 PCa cell lines (PC346C and VCaP) by ultracentrifugation. After tryptic digestion, proteomic analyses utilized a nanoLC coupled with an LTQ-Orbitrap operated in tandem MS (MS/MS) mode. Accurate Mass and Time (AMT) tag approach was employed for peptide identification and quantitation. Candidate biomarkers were validated by Western blotting and Immunohistochemistry.
Proteomic characterization resulted in the identification of 248, 233, 169, and 216 proteins by at least 2 peptides in exosomes from PNT2C2, RWPE-1, PC346C, and VCaP, respectively. Statistical analyses revealed 52 proteins differently abundant between PCa and control cells, 9 of which were more abundant in PCa. Validation by Western blotting confirmed a higher abundance of FASN, XPO1 and PDCD6IP (ALIX) in PCa exosomes.
Identification of exosomal proteins using high performance LC-FTMS resulted in the discovery of PDCD6IP, FASN, XPO1 and ENO1 as new candidate biomarkers for prostate cancer.
Publisher
Public Library of Science,Public Library of Science (PLoS)
Subject
/ Biology
/ Biomarkers, Tumor - metabolism
/ Calcium-Binding Proteins - metabolism
/ Cancer
/ Cell Cycle Proteins - metabolism
/ DNA-Binding Proteins - metabolism
/ Endosomal Sorting Complexes Required for Transport - metabolism
/ Exosomes
/ Fatty Acid Synthase, Type I - metabolism
/ Humans
/ Male
/ Medicine
/ Microscopy, Electron, Transmission
/ Neoplasm Proteins - metabolism
/ Peptides
/ Phosphopyruvate Hydratase - metabolism
/ Prostate
/ Prostatic Neoplasms - diagnosis
/ Prostatic Neoplasms - metabolism
/ Prostatic Neoplasms - ultrastructure
/ Proteins
/ Receptors, Cytoplasmic and Nuclear - metabolism
/ Tumor Suppressor Proteins - metabolism
/ Urine
/ Urology
